Generation of adeno-associated virus capsid libraries for insect cells

HK40137471APending Publication Date: 2026-09-11UNIQURE BIOPHARMA BV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
HK62026126287
Authority / Receiving Office
HK · HK
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-04-18
Filing Date
2026-07-17
Publication Date
2026-09-11

Smart Images

  • Figure 00000049_0000
    Figure 00000049_0000
  • Figure 00000050_0000
    Figure 00000050_0000
  • Figure 00000051_0000
    Figure 00000051_0000
Patent Text Reader

Abstract

The present invention relates to means and methods for generating adeno-associated virus capsid libraries using insect host cells. In particular, the invention relates to novel DNA constructs and methods using these constructs for generating adeno-associated virus capsid libraries in insect host cells that minimize the occurrence of cross-packaging and mosaicism in the libraries generated. The invention further relates to method for identifying AAV capsid variants with one or more desired characteristics, such as e.g. the combination of CNS tropism and detargeting of peripheral organs.
Need to check novelty before this filing date? Find Prior Art

Description

This invention relates to means and methods for generating adeno-associated virus (AAV) capsid libraries using insect host cells. In particular, this invention relates to novel DNA constructs and methods for generating AAV capsid libraries in insect host cells using these constructs, methods that minimize cross-packaging and chimerism in the resulting libraries. The invention further relates to methods for identifying AAV capsid variants having one or more desired characteristics, such as a combination of, for example, CNS tropism and peripheral organ detargeting. Abstract

Claims

Claims1 . A linear nucleic acid molecule comprising a nucleic acid construct comprising: i) a nucleotide sequence encoding an adeno-associated virus (AAV) capsid variant, wherein the nucleotide sequence encodes an mRNA, translation of which in an insect cell produces the AAV capsid variant, and wherein the nucleotide sequence is operably linked to a promoter for driving expression in an insect cell; ii) an enhancer element that is operably linked to the promoter, wherein the enhancer element is dependent on a transcriptional transregulator, and wherein introduction of the transcriptional transregulator into an insect cell comprising the nucleic acid construct, induces transcription from the promoter; iii) at least one AAV inverted terminal repeat (ITR) sequence; iv) optionally, a reporter gene operably linked to a promoter for driving expression in a mammalian cell; and, v) optionally, a barcode.

2. A nucleic acid molecule according to claim 1 , the transcriptional transregulator is a baculoviral immediate-early protein (IE1) or its splice variant (IE0) and the transcriptional transregulatordependent enhancer element is a baculoviral homologous region (hr) enhancer element, wherein preferably the baculovirus is Autographa californica multicapsid nucleopolyhedrovirus.

3. A nucleic acid molecule according to claim 2, wherein the hr enhancer element comprises at least one copy of the hr 28-mer sequence CTTTACGAGTAGAATTCTACGCGTAAAA and / or at least one copy of a of a sequence of which at least 20, 21 , 22, 23, 24, 25, 26, or 27 nucleotides are identical to sequence CTTTACGAGTAGAATTCTACGCGTAAAA and which binds to a baculoviral IE1 protein, and wherein the hr enhancer element, when operably linked to an expression cassette comprising a reporter gene operably linked to the polH promoter, a) under non-inducing conditions, the expression cassette with the hr enhancer element produces less reporter transcript than an otherwise identical expression cassette which comprises the hr2-0.9 element, or the cassette with the hr enhancer element produces less than a factor 1 .1 , 1 .2, 1 .5, 2, 5 or 10 of the amount reporter transcript produced by an otherwise identical expression cassette which comprises the hr4b element; and, b) under inducing conditions, the expression cassette with the hr enhancer element produces at least 50, 60, 70, 80, 90 or 100% of the amount of reporter transcript produced by an otherwise identical expression cassette which comprises the hr4b or the hr2-0.9 element,wherein more preferably the hr enhancer element is selected from the group consisting of hr1 , hr2-0.9, hr3, hr4b and hr5, of which hr4b and hr5 are preferred, of which hr4b is most preferred.

4. A nucleic acid molecule according to any one of the preceding claims, wherein the promoter for driving expression in an insect cell is a baculoviral promoter, preferably, a late or very late baculoviral promoter, more preferably, a promoter selected from the group consisting of the polH, p10, p6.9 and pSel120 promoters.

5. A nucleic acid molecule according to any one of the preceding claims, wherein the linear nucleic acid molecule is obtainable by digestion with a site specific endonuclease that cuts at a recognition sequence in the nucleic acid construct.

6. A nucleic acid molecule according to any one of the preceding claims, wherein at least one end of the linear nucleic acid molecule is protected against exonuclease degradation, preferably both ends of the linear nucleic acid molecule are protected against exonuclease degradation.

7. A nucleic acid molecule according to claim 5 or 6, wherein the endonuclease is a protelomerase, preferably a phage N15 TelN protelomerase, and wherein at least one end of the linear nucleic acid molecule is covalently closed, or wherein preferably both ends of the linear nucleic acid molecule are covalently closed.

8. A nucleic acid molecule according to any one of claims 5 to 7, wherein the locations of elements i) to v) and the recognition sequence in the construct are such that expression of AAV Rep proteins in an insect cell comprising the nucleic acid construct, effects replication and packaging into AAV capsids of a DNA fragment comprising elements i) to v).

9. A nucleic acid molecule according to any one of the preceding claims, wherein the nucleic acid construct comprises in a 5’ to 3’ order: a) a first AAV ITR sequence; b) the enhancer element; c) an expression cassette comprising the nucleotide sequence encoding the AAV capsid variant, operably linked to the promoter for driving expression in the insect cell; and, d) a second AAV ITR, wherein the recognition sequence is present at at least one of i) upstream of the first AAV ITR and ii) downstream of the second AAV ITR, wherein optionally, the reporter gene operably linked to the promoter for driving expression in a mammalian cell is present between a) and b), b) and c) or c) and d), and wherein optionally, a barcode is present between a) and b), b) and c) or c) and d)and wherein, preferably the recognition sequence is a unique recognition sequence.

10. A nucleic acid molecule according to any one of the preceding claims, wherein at least one of: a) the promoter for driving expression in a mammalian cell is a cell type and / or tissue specific promoter, preferably a promoter selected from the group consisting of human synapsin promoter (hSynl), transthyretin promoter (TTR), cytokeratin 18, cytokeratin 19, unc-45 myosin chaperon B (unc45b) promoter, cardiac troponin T (cTnT) promoter, glial fibrillary acidic protein (GFAP) promoter, myelin basic protein (MBP) promoter, and methyl-CpG-binding protein 2 (Mecp2) promoter; b) the reporter gene encodes a colorimetric, fluorescent or bioluminescent reporter protein, preferably a reporter protein is selected from the group consisting of: secreted alkaline phosphatase (SEAP), p-galactosidase EGFP, mCherry, mCloverS, mRubyS, mApple, iRFP, tdTomato, mVenus, YFP, RFP, firefly luciferase, sea pansy luciferase and nanoluciferase; and, c) the barcode is a nucleotide sequence of 4 - 18 nucleotides long.

11. A library comprising a plurality of nucleic acid molecules comprising a construct as defined in any one of claim 1 - 10, wherein, in each member of the library, the nucleotide sequence encoding the AAV capsid variant differs by at least one nucleotide from nucleotide sequences encoding the AAV capsid variants in other members in the library, and wherein preferably, in each member of the library, the nucleotide sequence encoding the AAV capsid variant, encodes a capsid variant that differs by at least one amino acid from AAV capsid variants encoded by other members in the library.

12. An insect cell comprising a nucleic acid molecule comprising a construct as defined in any one of claim 1 - 10, or a library as defined in claim 11 .

13. An insect cell according to claim 12, further comprising a baculoviral vector comprising at least one expression cassette for expression of AAV Rep proteins in the insect cell.

14. A library comprising a plurality of AAV capsid variants, wherein members in the library comprise a nucleic acid that is replicated and packaged from a member in the library of nucleic acid constructs as defined in claim 11 .

15. A method for preparing a library of AAV capsid variants, the method comprising the steps of: a) providing a library comprising a plurality of nucleic acid construct as defined in any one of claims 1 - 10, wherein the amino acid sequence of an AAV capsid variant of each member in the library as encoded in the construct of that member, differs by at least oneamino acid from amino acid sequences of AAV capsid variants encoded in constructs of other members in the library; b) amplifying the library of the nucleic acid constructs obtained in a), preferably by rolling circle amplification; c) digestion of the amplified library of the nucleic acid constructs obtained in b) by the endonuclease to produce a library comprising linearised amplified nucleic acid constructs of unit length; d) transfection of the library comprising linearised amplified nucleic acid constructs obtained in c) into insect cells; e) infection of the insect cells with a baculoviral vector comprising at least one expression cassette for expression of AAV Rep proteins in the insect cells and culturing of the cells; and, f) recovery of a library of AAV capsid variants produced by the insect cells in e).

16. A method according to claim 15, wherein the library in a) is provided by: i) providing a nucleic acid construct as defined in any one of claims 1 - 10; and, ii) replacing a fragment comprising at least a part of the nucleotide sequence encoding the AAV capsid variant in the construct, by a library of fragments, wherein the amino acid sequence of an AAV capsid variant of each member in the library as encoded in the fragment of that member, differs by at least one amino acid from amino acid sequences of AAV capsid variants encoded in constructs of other members in the library.

17. A method according to claim 16, wherein:- in step ii) of claim 16, the replacement is performed by Gibson assembly;- in step b) of claim 15, the rolling circle amplification is performed by using a <t>29 DNA polymerase, preferably, in combination with random primers; and / or,- in c) of claim 15, the ends of the linearised amplified library of the nucleic acid constructs of unit length are provided with protection against against exonuclease degradation.

18. A method according to any one of claims 15 to 17, wherein:- in step c) of claim 15, the endonuclease is a phage N15 TelN protelomerase, providing covalently closed ends to the linearised amplified library of the nucleic acid constructs of unit length.

19. A method for identifying an AAV capsid variant with a desired characteristic, the method comprising: a) providing a library of AAV capsid variants as defined in claim 14, or as obtained in a method according to any one of claims 15 to 18; b) contacting the library with a culture of cells, an organoid or a tissue, or administering the library to a non-human animal;c) allowing AAV capsid variants in the library to transduce the cells, the organoid, the tissue or cells in the animal; and, d) identifying at least one AAV capsid variant that has transduced at least one desired cell-type in the cells, the organoid, the tissue or in the animal in b), as an AAV capsid variant with the desired characteristic, and optionally recovery of the AAV capsid variant with the desired characteristic from the desired cell.

20. A method according to claim 19, wherein step d) comprises detection of transduction of at least the desired cell by detecting expression of the reporter gene in the desired cell.21 . A method according to claim 19 or 20, wherein the variant with the desired characteristic is identified by sequencing at least one of i) the barcode and ii) a region of the DNA construct encoding the at least one amino acid difference.